UNSPSC 51282314: Erythromycin e

This classification denotes a macrolide antibiotic with the molecular formula C37H65NO14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 39V2DI8XOX, chemically known as erythromycin, 1'',16-epoxy-, but more generally known as erythromycin e, which bears US NIH Compound Identifier 5462331. European Medicines Agency schedules erythromycin e or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06605MIG. Most nations, for tariff purposes, schedule erythromycin e under HS 29415000.

SMILES: CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@H]2[C@@H](CO[C@]3(O2)C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C(=O)O1)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)N(C)C)O)(C)O)C)C)O)(C)O.

UNSPSC 51282314 Erythromycin e is a Commodity code that does not align with recent state and local procurement activity under this classification. The four most recent opportunities tagged to this code procure naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic multi-source pharmaceuticals and OTC products through a multistate cooperative purchasing alliance, and pharmacy benefit program direct-to-manufacturer prescription services — none of which are erythromycin or erythromycin-specific pharmaceutical products. The mismatch suggests either misclassification of opportunities at the issuing-body level or that state and local governments use this commodity code inconsistently across jurisdictions. State and local procurement offices, county health departments, fire departments, and multistate cooperative purchasing organizations appear in the recent opportunities block, but the actual work being solicited does not match the code's stated scope.

No recent state and local opportunities for erythromycin products are present in the source material. The code shows activity in Florida (Seminole County), Texas (Health and Human Services Commission), Minnesota (MMCAP multistate cooperative), and Oregon (MMCAP participant), but these opportunities address broader pharmaceutical procurement categories rather than erythromycin-specific solicitations. Seminole County's IFB 60459723LAS posted June 30, 2026, the City of Tampa's ITB 26P00145 posted March 25, 2026, Texas HHS's RFI HHS0017013 posted April 3, 2026, and Minnesota MMCAP's RFP S1070000015802 posted January 20, 2026, all represent pharmaceutical or medical supply procurement activity that falls outside the erythromycin commodity code's nominal scope.